All stock lists
Privia Health Group, Inc. (PRVA)
NASDAQ: PRVA · Real-Time Price · USD
Healthcare · Health Information Services
22.20-0.21 (-0.94%)
Insider Score
––Not scored
PRVA Insider Score
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
PRVA analyst forecast
Best analysts covering PRVA
- Evercore ISI Group100%success rate · 3 calls
- Canaccord Genuity57%success rate · 7 calls
- Truist Securities50%success rate · 6 calls
- Stephens & Co.50%success rate · 4 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
PRVA analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Barclays | Equal Weight | — | — | Reiterated | 2026-05-26 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-05-08 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2026-04-08 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2026-03-25 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-03-03 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-03-02 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-02-27 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2025-12-04 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2025-11-13 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2025-11-12 |
| — | Truist Securities | Buy | — | — | Reiterated | 2025-11-10 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2025-11-10 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2025-11-07 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2025-11-07 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2025-10-09 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2025-09-24 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2025-09-04 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2025-08-29 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2025-08-11 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2025-07-09 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2025-05-28 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2025-05-27 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2025-04-28 |
| — | Baird | Outperform | — | — | Reiterated | 2025-04-15 |
| — | Truist Securities | Buy | — | — | Reiterated | 2025-04-10 |
| — | Needham | Buy | — | — | Reiterated | 2025-04-10 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2025-04-10 |
| — | Needham | Buy | — | — | Reiterated | 2025-03-21 |
| — | Citizens Capital Markets | Market Outperform | — | — | Reiterated | 2025-02-28 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2025-02-28 |
| — | Needham | Buy | — | — | Reiterated | 2025-02-28 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2025-02-28 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2025-02-14 |
| — | Needham | Buy | — | — | Reiterated | 2025-01-15 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2025-01-07 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2025-01-02 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2024-11-29 |
| — | Truist Securities | Buy | — | — | Reiterated | 2024-11-08 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2024-11-08 |
| — | Baird | Outperform | — | — | Reiterated | 2024-08-26 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2024-08-14 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2024-07-09 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2024-05-20 |
| — | Truist Securities | Buy | — | — | Reiterated | 2024-05-15 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2024-05-10 |
| — | Stifel | Buy | — | — | Reiterated | 2024-05-01 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2024-03-19 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2024-03-06 |
| — | TD Cowen | Outperform | — | — | Reiterated | 2024-03-01 |
| — | UBS | Buy | — | — | Reiterated | 2024-03-01 |
| — | Truist Securities | Buy | — | — | Reiterated | 2024-02-29 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2024-02-28 |
| — | B of A Securities | Neutral | — | — | Downgraded | 2024-02-22 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2023-11-17 |
| — | UBS | Buy | — | — | Reiterated | 2023-08-18 |
| — | TD Cowen | Outperform | — | — | Reiterated | 2023-08-15 |
| — | Credit Suisse | Outperform | — | — | Reiterated | 2023-06-22 |
| — | SVB Leerink | Outperform | — | — | Reiterated | 2022-11-11 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2022-11-11 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2022-08-25 |
PRVA earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-26 | 0.04 | 0.07 | $516.2M | $541.2M |
| 2026-05-07 | 0.08 | 0.02 | $561.0M | $603.8M |
| 2026-08-06 | 0.07 | 0.07 | $597.3M | $632.6M |
| 2026-11-05 | 0.09 | 0.00 | $610.7M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.